Unexpected co-detection of promastigote and amastigote Leishmania forms in a human cutaneous lesion: implications for leishmaniasis physiopathology and treatment

Diagn Microbiol Infect Dis. 2015 Jan;81(1):18-20. doi: 10.1016/j.diagmicrobio.2014.09.014. Epub 2014 Sep 22.

Abstract

Cutaneous leishmaniasis pathogenicity depends on the survival and replication of the parasitic protozoa in the form of non-motile amastigotes inside macrophages. Here, we report the unprecedented observation of both Leishmania major amastigote and promastigote forms (the latter is normally detected only in the mid gut of the insect vector or in vitro culture) in a cutaneous lesion of a 6-year-old boy. This finding suggests that modifications of the skin lesion environment, such as maceration and changes in pH or temperature, could promote the in situ transformation of Leishmania amastigotes into promastigotes. This observation raises questions about the physiopathology of cutaneous leishmaniasis and the influence of micro-environmental changes on the efficiency of topical treatments.

Keywords: Cutaneous lesion; Leishmania promastigote; Maceration; Physiopathology.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Betamethasone / administration & dosage
  • Betamethasone / therapeutic use
  • Child
  • Fusidic Acid / administration & dosage
  • Fusidic Acid / therapeutic use
  • Humans
  • Hydrogen-Ion Concentration
  • Leishmania major / pathogenicity*
  • Leishmania major / physiology*
  • Leishmaniasis, Cutaneous / drug therapy
  • Leishmaniasis, Cutaneous / parasitology*
  • Leishmaniasis, Cutaneous / pathology*
  • Male
  • Tunisia

Substances

  • Fusidic Acid
  • Betamethasone